Cargando…
Pioglitazone Improved Insulin Sensitivity and First Phase Insulin Secretion Among Obese and Lean People with Diabetes: A Multicenter Clamp Study
INTRODUCTION: To investigate the effects of pioglitazone (PIO) on insulin resistance and first phase insulin secretion among obese and lean Chinese people with type 2 diabetes mellitus (T2DM). METHODS: Sixty-eight drug-naïve patients with T2DM were treated with PIO for 16 weeks. Before and after the...
Autores principales: | Qian, Xin, Wang, Hui, Yang, Gangyi, Gao, Zhengnan, Luo, Yong, Dong, Aimei, Zhang, Fang, Xu, Mingtong, Liu, Shiping, Yang, Xin, Chen, Yanyan, Li, Guangwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104278/ https://www.ncbi.nlm.nih.gov/pubmed/29536426 http://dx.doi.org/10.1007/s13300-018-0401-9 |
Ejemplares similares
-
Pioglitazone Acutely Reduces Energy Metabolism and Insulin Secretion in Rats
por: Lamontagne, Julien, et al.
Publicado: (2013) -
Pioglitazone Increases Whole Body Insulin Sensitivity in Obese, Insulin-Resistant Rhesus Monkeys
por: Tozzo, Effie, et al.
Publicado: (2015) -
Effects of Pioglitazone on Insulin Sensitivity and Serum Lipids in Obese Cats
por: Clark, M., et al.
Publicado: (2013) -
The effects of increased acetate turnover on glucose-induced insulin secretion in lean and obese humans
por: Petersen, Kitt Falk, et al.
Publicado: (2019) -
Multiorgan Insulin Sensitivity in Lean and Obese Subjects
por: Conte, Caterina, et al.
Publicado: (2012)